Madrone Opportunity Fund Reports 5.6% Holding in PACB
Rhea-AI Filing Summary
Multiple related parties reported material holdings in Pacific Biosciences (PACB). Madrone Opportunity Fund directly holds 16,762,216 shares (5.6% of class) and Shimoda Holdings directly holds 3,500,000 shares (1.2%). Gregory Boyd Penner is reported as an individual with aggregate beneficial ownership of 20,262,216 shares (6.8% of class), reflecting his roles across the filing entities.
The filing discloses that the reported shares carry shared voting and shared dispositive power among the reporting persons and that the percentage figures are calculated using 300,084,685 shares outstanding as the denominator. The reporting persons expressly disclaim status as a "group."
Positive
- Aggregate beneficial ownership disclosed: Gregory Penner reports 20,262,216 shares (6.8%) of PACB, a material position.
- Madrone Opportunity Fund transparency: Direct holding of 16,762,216 shares (5.6%) clearly reported.
- Clear voting/dispositive power disclosure: Filing states shared voting and shared dispositive power for reported positions.
- Percentage basis provided: Ownership percentages use 300,084,685 shares outstanding for calculation.
Negative
- None.
Insights
TL;DR: Combined holdings represent a meaningful >5% stake, with shared voting power across related entities.
The Schedule 13G/A shows clear, quantifiable positions: Madrone Opportunity Fund holds 16,762,216 shares (5.6%) and Shimoda holds 3,500,000 shares (1.2%), producing an aggregate beneficial ownership for Gregory Penner of 20,262,216 shares (6.8%). Reported authority is shared voting and shared dispositive power, which signals coordinated control over disposition and voting of these shares even as the filing explicitly disclaims group status. The percent basis is disclosed as 300,084,685 shares outstanding, giving clarity to the stake magnitude.
TL;DR: Managers and entities report overlapping authority; formal disclaimer of a "group" contrasts with shared powers disclosed.
The filing documents that Madrone GP, as general partner of Madrone Opportunity Fund, and managers (Penner, McJunkin, Patterson) share voting and investment authority over Madrone's 16,762,216-share position. Shimoda's 3,500,000-share position is managed in part by Penner. While the Reporting Persons "expressly disclaim" group status, the combination of shared voting and shared dispositive power is governance-relevant and amounts to a substantive disclosure for investors assessing potential influence on issuer decisions.
FAQ
Who filed the Schedule 13G/A for Pacific Biosciences (PACB)?
What holdings does Madrone Opportunity Fund report in PACB?
Does the filing state whether the reporting persons have voting or dispositive power?
Do the reporting persons claim to be a group under the Schedule 13G/A?
Was the ownership reported as held for the purpose of changing control of PACB?